ORM1 and Miyoshi myopathy: The beneficial effect of increasing ORM1 in our MM models (via pregnenolone treatment, which raised ORM1 levels and slowed MM cell growth) highlights a potential therapeutic strategy: enhancing ORM1 activity might suppress MM progression.